Skip to main content

Table 2 Outcomes

From: Preoxygenation with standard facemask combining apnoeic oxygenation using high flow nasal cannula versuss standard facemask alone in patients with and without obesity: the OPTIMASK international study

 

Overall (n = 450)

Facemask alone (n = 233)

Facemask combined with HFNO (n = 217)

Absolute differences (95% CI)

Relative risks (95% CI)

p value

Primary: lowest EtO2 within 2 min after intubation (%)a

90 (87–92)

89 (85–92)

91 (88–93)

− 2.20 (− 3.21 to − 1.18)

 < 0.001

Secondary:

 SpO2 at the end of preoxygenation (%)

100 (100–100)

100 (100–100)

100 (100–100)

0.02 (− 0.08 to 0.12)

 

0.56

 First EtO2 after intubation (%)b

91 (88–96)

90 (87–96)

92 (89–97)

− 1.64 (− 2.83 to − 0.45)

0.004

 Highest EtCO2 after intubation (%)c

37 (34–40)

37 (34–40)

37 (33–41)

0.83 (− 0.21 to 1.87)

0.26

 Lowest EtCO2 within 2 min after intubation (%)c

35 (32–38)

35 (32–38)

35 (32–38)

0.76 (− 0.22 to 1.73)

0.38

 First SpO2 after intubation (%)d

100 (100–100)

100 (100–100)

100 (100–100)

− 0.56 (− 1.17 to 0.05)

0.39

 Lowest SpO2 during intubation and within 2 min after intubation (%)d

100 (99–100)

100 (99–100)

100 (99–100)

− 0.64 (− 1.36 to 0.09)

0.41

 SpO2 ≤ 95% during intubation and within 2 min after intubation

16/447 (3.6)

14/232 (6.0)

2/215 (0.93)

0.05 (0.02 to 0.09)

6.84 (1.54 to 30.5)

0.004

 Ease of use of preoxygenation (from 0 to 10)e

9 (8–10)

10 (9–10)

8 (7–9)

1.74 (1.36 to 2.11)

 < 0.001

 First-attempt success

416/441 (94.3)

210/225 (93.3)

206/216 (93.4)

− 0.02 (− 0.06 to 0.02)

0.68 (0.30 to 1.55)

0.36

 Excellent conditions of intubation

253/406 (62.3)

127/209 (60.8)

126/197 (64.0)

− 0.03 (− 0.13 to 0.06)

0.87 (0.58 to 1.31)

0.51

  1. Data are n/N (%), and median (IQR)
  2. SpO2 Peripheral oxygen saturation, EtO2 end-tidal oxygen, EtCO2 end-tidal carbon dioxide, HFNO High-Flow Nasal cannula Oxygen, NA Not Applicable
  3. aData on lowest EtO2 after intubation were missing for 0 patients (0%) in the facemask alone group and 2 (1.0%) in the facemask combined with HFNO group
  4. bData on first EtO2 after intubation were missing for 9 patients (3.9%) in the facemask alone group and 4 (1.8%) in the facemask combined with HFNO group
  5. cData on highest and lowest EtCO2 after intubation were missing for 0 patients (0%) in the facemask alone group and 2 (1.0%) in the facemask combined with HFNO group
  6. dData on first and lowest SpO2 after intubation were missing for 0 patients (0%) in the facemask alone group and 2 (1.0%) in the facemask combined with HFNO group
  7. eData on ease of use of preoxygenation were missing for 73 patients (31.3%) in the facemask alone group and 49 (22.6%) in the facemask combined with HFNO group